Ref.: BL-RE-093307Manufacturer ref.: ERCLUX10 10 x 96 tests
€4,815.00 excl. VAT
The isoform 1 works as an extracellular chaperone that prevents the aggregation of non-native proteins. Prevents aggregation induced by stress of blood plasma proteins. Inhibits the formation of amyloid fibrils by variants...
Accession number
P05371
Dose range
1.311 to 320 ng/ml
Sensitivity of the dosage
1.3 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
The isoform 1 works as an extracellular chaperone that prevents the aggregation of non-native proteins. Prevents aggregation induced by stress of blood plasma proteins. Inhibits the formation of amyloid fibrils by variants...
The isoform 1 works as an extracellular chaperone that prevents the aggregation of non-native proteins. Prevents aggregation induced by stress of blood plasma proteins. Inhibits the formation of amyloid fibrils by LYZ variants (in vitro) subject to aggregation and APP, APOC2, B2M, CALCA, CSN3 and SNCA. Does not require ATP. Maintains partially unfolded proteins in a suitable state for subsequent folding by other chaperones, such as HSPA8 / HSC70. Don't fold the protein in itself. The binding to cell surface receptors triggers the internalization of the client-chaperon complex and subsequent lysosome or proteosomal degradation. The secreted isoform 1 protects the cells against apoptosis and complement cytolysis. Intracellular isoforms interact with the complexes of diubiquitin and SCF (protein SKP1-CUL1-F-box) E3 ubiquitin-protein ligase and promote ubiquitination and subsequent proteosome degradation of the target proteins. Promotes proteosomal degradation of COMMD1 and IKBKB. Module of transcriptional activity NF-kappa-B. Nuclear isoforms promote apoptosis. Mitochondrial isoforms inhibit the release of BAX-dependent cytochrome c into the cytoplasm and inhibit the apoptosis. Plays a role in regulating cell proliferation.
Sensitivity
Sensitivity of the dosage: 1.3 ng/ml.
Measurement range
Dose range: 1.311 to 320 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.